Minoxidil
-
Subject Areas on Research
- A falling out following minoxidil: telogen effluvium.
- A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
- A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
- Characterization of a partial cDNA for lysyl hydroxylase from human skin fibroblasts; lysyl hydroxylase mRNAs are regulated differently by minoxidil derivatives and hydralazine.
- Current and novel methods for assessing efficacy of hair growth promoters in pattern hair loss.
- Dose-response study of topical minoxidil in male pattern baldness.
- Effect of ultraviolet light on topical minoxidil-induced hair growth in advanced male pattern baldness.
- Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study.
- Evaluation and treatment of male and female pattern hair loss.
- Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee.
- Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil.
- Human skin and platelet minoxidil sulfotransferase activities: biochemical properties, correlations and contribution of thermolabile phenol sulfotransferase.
- Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis.
- Inhibition of cultured human RPE cell proliferation and lysyl hydroxylase activity by hydroxy derivatives of minoxidil.
- Long-term follow-up of men with male pattern baldness treated with topical minoxidil.
- Minoxidil inhibits ocular cell proliferation and lysyl hydroxylase activity.
- My hair is thinning on the top of my head. What treatments are available for hair loss in women?
- Regulation of lysyl oxidase mRNA in dermal fibroblasts from normal donors and patients with inherited connective tissue disorders.
- Scalp comedones after topical minoxidil.
- Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
- Topical minoxidil in early male pattern baldness.
- Topical minoxidil in male pattern baldness: effects of discontinuation of treatment.
- Topical minoxidil in the treatment of androgenetic alopecia in women.
- Treatment of chemotherapy-induced alopecia.